Horizon Financial Services’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.6K Buy
+357
New +$20.5K 0.01% 256
2026
Q1
Sell
-100
Closed -$5.39K 377
2025
Q4
$5.39K Buy
+100
New +$4.81K ﹤0.01% 252
2025
Q1
Sell
-50
Closed -$2.83K 301
2024
Q4
$2.83K Hold
50
﹤0.01% 159
2024
Q3
$2.59K Hold
50
﹤0.01% 167
2024
Q2
$2.08K Hold
50
﹤0.01% 172
2024
Q1
$2.71K Buy
+50
New +$2.55K ﹤0.01% 168

Other funds holding BMY

Horizon Financial Services's BMY Position: Q2 2026 in Review

Horizon Financial Services opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 357 shares worth $20.6K. The stake represents 0.01% of the portfolio and ranks #256 among its holdings. This is a return to the name: Horizon Financial Services previously reported a position in BMY as recently as Q4 2025.

Horizon Financial Services first reported a position in BMY in Q1 2024 and has held it in 6 quarters since. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Horizon Financial Services held 357 shares of Bristol-Myers Squibb worth $20.6K as of Q2 2026.
  • Bristol-Myers Squibb was a new Horizon Financial Services position in Q2 2026.
  • Bristol-Myers Squibb made up 0.01% of Horizon Financial Services's portfolio in Q2 2026, its #256 holding.
  • Horizon Financial Services first reported a position in Bristol-Myers Squibb in Q1 2024 and has held it in 6 quarters since.
  • 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Horizon Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.